ITMCTR2100005479尚未招募1 期
Clinical study on the application of extracorporeal shock wave in the treatment of early and middle stage knee osteoarthritis based on the meridian sinew theory
The Third Medical Center of Chinese People's Liberation Army General Hospital0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 40 至 75（—）
- 性别
- All
入选标准
- •(1)The patient's diagnostic criteria were in line with the above-mentioned western diagnostic criteria and traditional Chinese diagnostic criteria;
- •(2)The patients were between 40 and 75 years old;
- •(3)Patients who have not received systematic treatment recently have not taken painkillers
- •(4)Subjects with limited joint flexion and extension activities due to traction pain at the back of the knee joint with or without other meridian sinew types
- •(5)The subjects voluntarily participated in the study, signed the informed consent, and were willing to cooperate in filling in relevant data and receiving follow-up visits.
排除标准
- •(1)Patients with Kellgren-Lawrence grade IV radiographic manifestations, significant narrowing of joint space and subchondral sclerosis;
- •(2)Subjects who had received arthroscopic surgery or open surgery for the previously diseased knee;
- •(3)Patients with other rheumatic immune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, psoriatic arthritis, ankylosing spondylitis, etc
- •(4)Patients with secondary knee OA, such as acute and chronic knee infection, tumor, tuberculosis, hematological and traumatic diseases
- •(5)Patients with severe knee deformity, varus > 10°, varus > 20°, and complete loss of joint space are not suitable for conservative treatment
- •(6)Patients with serious primary cardiovascular disease, lung disease, metabolic disease, endocrine disease, abnormal coagulation mechanism or other serious diseases affecting survival
- •(7)In the last 3 months, the patient received acetaminophen, chondrotrophic drugs, articular cavity injection drugs and other related treatments
- •(8)Patients who cannot cooperate with MRI examination and have contraindications for MRI examination;
- •(9)Patients with contraindications of extracorporeal shock wave therapy;
- •(10)Pregnant or lactating women;
- •(11)The patient is suspected or has a history of alcohol or drug abuse, or has other medical conditions that, in the judgment of the investigator, may reduce the possibility of enrollment or complicate enrollment, or may cause loss of follow-up;
- •(12) Patients with serious adverse reactions and contraindications of celecoxib capsules;
- •(13) Other circumstances in which the researcher considers that the experiment cannot be successfully completed.
- •If subjects meet any of the above criteria, they are excluded cases.
研究者
相似试验
已完成
2 期
Study the effects of lithotripsy in renal cyst formatioCondition 1: Renal Stone. Condition 2: Renal Cyst.Calculus of kidneyCyst of kidney, acquiredIRCT201607179904N2Vice Chancellor for research of Tabriz University of Medical Sciences60
已完成
不适用
Extracorporeal shock wave therapy (ESWT) and kinesiotherapy (KIN) on women with bilateral knee osteoarthritisknee painMusculoskeletal - OsteoarthritisPhysical Medicine / Rehabilitation - PhysiotherapyosteoarthritisACTRN12616000589482Holycross College60
进行中（未招募）
1 期
A clinical study in patients with moderate to severe graft-versus-host disease, patients randomly assigned to standard of care or to standard of care plus Extracorporeal (ECP) Therapy with UVADEX™EUCTR2010-022780-35-HUTHERAKOS, Inc.60
进行中（未招募）
不适用
A clinical study in patients with moderate to severe graft-versus-host disease, patients randomly assigned to standard of care or to standard of care plus Extracorporeal (ECP) Therapy with UVADEX™Chronic graft-versus-host disease (cGvHD)MedDRA version: 14.1Level: PTClassification code 10018651Term: Graft versus host diseaseSystem Organ Class: 10021428 - Immune system disordersEUCTR2010-022780-35-ITTHERAKOS60
进行中（未招募）
1 期
A clinical study in patients with moderate to severe graft-versus-host disease, patients randomly assigned to standard of care or to standard of care plus Extracorporeal (ECP) Therapy with UVADEX™Chronic graft-versus-host disease (cGvHD)MedDRA version: 14.1 Level: PT Classification code 10018651 Term: Graft versus host disease System Organ Class: 10021428 - Immune system disordersEUCTR2010-022780-35-GBTHERAKOS, Inc.60